Trial Profile
Phase Ia first-in-human, single rising dose trial of oral BI 224436 in healthy male volunteers.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 22 Feb 2012
Price :
$35
*
At a glance
- Drugs BI 224436 (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 22 Feb 2012 New trial record